BiCycle
Business Intelligence (BI) Software · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Charlotte, North Carolina, United StatesWebsite
www.bicyclebi.bizRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About BiCycle
BICycle offers a comprehensive Business Intelligence (BI) and analytics platform that enables users to launch BI initiatives in just 30 days, powered by advanced AI technology from Pyramid Analytics. Their platform supports automated data retrieval from various sources, providing real-time insights and allowing for flexible visualizations and reporting tailored to business needs. Targeting businesses looking to enhance their decision-making processes and optimize operations, BICycle emphasizes user-friendly interfaces and quick implementation. With a team of experienced consultants, BICycle ensures a custom approach to each project, guaranteeing quality and support throughout the engagement.Explore more
BiCycle Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BiCycle your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when BiCycle launches new products
BiCycle, which may be a good buyer, showed buying intent in Masked Content Topic
Check if BiCycle has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once BiCycle has new funding data
Click to see if BiCycle had a recent Job posting/layoffs
Check out if BiCycle is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at BiCycle
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on BiCycle recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined BiCycle as Masked Content
Find 2 more new buyers
Compare Similar Companies to BiCycle
Compare insights from companies similar to BiCycle, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BiCycle is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
BiCycle is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about BiCycle.
BiCycle Tech Stack
A closer look at the technologies used by BiCycle
BiCycle News & Media
Bicycle Therapeutics Announces FDA Fast Track Designation Granted to BT8009 for the Treatment of Adult Patients with Previously Treated Locally Advanced or Metastatic Urothelial Cancer
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Bicycle’s BT8009 monotherapy for the treatment of adult patients with previously treated locally advanced or metastatic urothelial cancer. BT8009 isBicycle Therapeutics to Present Five Posters Highlighting Preclinical Data from its Bicycle Tumor-Targeted Immune Cell Agonist® (Bicycle TICA®) Programs at the SITC 37th Annual Meeting
CAMBRIDGE, England, & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that preclinical data for BT7480, a novel Bicycle tumor-targeted immune cell agonist (Bicycle TICA), and BT7455, an EphA2/CD137 Bicycle TICA, will be presented in five poster presentations at the Society for Immunotherapy of Cancer’s (SITC) 37th AnnBicycle Therapeutics Announces First Patient Dosed in BT8009 Phase II Expansion Cohorts and Provides Program Update
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced updates from the Phase I/II trial of BT8009 in patients with numerous cancer types where Nectin-4 is expressed. BT8009 is a potential first in class Bicycle Toxin Conjugate (BTC®) targeting Nectin-4, a protein located on the surface of cells that isBicycle Therapeutics to Participate in Upcoming Investor Conferences
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in the following investor conferences in November and December: Cowen’s 6th Annual IO Next Summit on Friday, November 11, 2022; fireside chat at 9:10 a.m. ET Jefferies London Healthcare Conference on Thursday, Novembe
Read more news
Top Business Intelligence (BI) Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BiCycle
Sign Up For FreeTo access detailed company insights
BICycle offers a comprehensive Business Intelligence (BI) and analytics platform that enables users to launch BI initiatives in just 30 days, powered by advanced AI technology from Pyramid Analytics. Their platform supports automated data retrieval from various sources, providing real-time insights and allowing for flexible visualizations and repor... Read More
